Expression of Gb3Cer/CD77-GSLs in pancreatic and colon carcinomas.

*Based on the secondary densitometric data, tumors were grouped into categories I to IV corresponding to high (I) and moderate (II) overexpression, equal (III) and lowered expression (IV).
†The 21 pancreatic tumors were ranked from 1 to 21 and the 16 colon tumors from 1 to 16, whereby rank 1 indicates the highest, rank 2 the second highest, etc., and the last rank the lowest expression of Gb3Cer/CD77.
‡Histopathologic grading: G1, well differentiated; G2, moderately differentiated; G3, poorly differentiated; G4, undifferentiated; GX, histopathologic grading cannot be assessed.